InvestorsHub Logo
Followers 11
Posts 898
Boards Moderated 0
Alias Born 09/10/2019

Re: misiu143 post# 160646

Thursday, 04/22/2021 9:30:18 AM

Thursday, April 22, 2021 9:30:18 AM

Post# of 232880
I doubt Remdesivir or Lenzilumab will be considered by physicians for csp often, if the physician has to take responsibility for the results. I know I wouldn't. Amazing that leronlimab is so safe and effective compared to SOC, yet people continue to bash. I hope leronlimab achieves worldwide acceptance, so the goal of saving lives is once again the goal imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News